"As an industry leader in delivering world class diagnostics, bringing innovative new drugs to market, and using data to change the way care is delivered, we are excited to provide new tools to biotechnology and pharmaceutical companies to enhance our understanding of an individual's cellular and genomic health." LabCorp is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. With combined revenue proforma for the acquisition of Covance in excess of $8.5 billion in 2014 and more than 48,000 employees in over 60 countries, LabCorp offers innovative solutions to healthcare stakeholders, including physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs.